web3: Akash launches Homenode public beta, AKT approaches key price level
AKT has recently been consolidating around $0.522. Previously, this token rebounded from a low of approximately $0.291 in March 2026, but the recovery has not yet fully stabilized. The market is now watching to see whether it can regain the 200-day moving average near $0.60.
Recovery emerged after the March low
AKT briefly broke above $2 at the end of May 2025, then continued to weaken over the following months, with lower highs and lows, and was repeatedly blocked below the $1.812 region and the long-term moving averages.
This decline temporarily halted in early March 2026 near $0.291. During March and April, the price gradually formed a structure of higher lows, and in late April broke out upwards, reaching up to $0.859 at the end of May and beginning of June.
$0.60 remains overhead resistance

However, after AKT tested $0.859 twice, its momentum weakened, and later it dropped below the 200-day moving average. In early August, the price even fell to about $0.480.
According to the original analysis, $0.501 is the key level to watch on the downside to determine whether the recovery structure can be maintained. If the price climbs back above $0.60, market expectations for a continued rebound may increase, and $0.859 would once again become the main resistance zone.
If it falls below $0.501, the price may revisit lower supports, potentially approaching the previously formed local bottom region.
Akash advances Homenode public test
While the price awaits a directional move, Akash is also pushing forward with ecosystem updates. The project team has launched Akash Homenode into public testing and introduced the node deployment method, revenue calculation, and the operational model for home nodes to earn AKT.
This progress does not directly alter the current price structure but offers the market a new point of observation. In the short term, $0.501, $0.60, and $0.859 remain the key levels for AKT within its current range.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
0.8550: Euro tests one-week highs against British Pound amid ECB hawkish bets
OceanaGold agrees to buy Ausgold in A$ 776 million share-and-cash deal
Defence Therapeutics appoints Ryan Simms as COO, radiopharmaceutical programs head
